Delivery Order SPE2DB20D2104-SPE2DB23FS56Y
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,361.39 for the supply of Biktarvy 50-200-25 30S, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense. The contract has an ultimate completion date of December 27, 2023 and is a firm fixed-price delivery order. Amerisourcebergen holds a larger Indefinite...
- This federal contract award, valued at $33,331.49, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 and runs through November 2026. The contract covers the delivery of various pharmaceutical products, including the medication Biktarvy, to support military...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a delivery order valued at $1,496.44 for the supply of the antiretroviral medication BIKTARVY. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with a performance period through March 11, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order worth $76,466.38 awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has an ultimate completion date of March 1, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award, valued at $5,654.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $22,993.49 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The DO is for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S, with a performance period through December 22, 2023. The contract was awarded on December 21, 2022 and does not have a set-aside designation, indicating full and open...
- This federal contract award, valued at $75,004.63, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. The contract provides for the delivery of pharmaceutical products, including the medication Biktarvy, to support military treatment facilities...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,637.49, is a delivery order for the drug BIKTARVY 50-200-25 30S. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $66,908.59 contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $111,081.78, is for the delivery of Biktarvy 50-200-25 mg tablets to support military and veterans' healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS56YDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which does not have a set-aside designation, covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. This specific Delivery Order, valued at $6,404.28, is for the supply of the antiretroviral medication Biktarvy. As a major pharmaceutical distributor, Amerisourcebergen plays a crucial role in supporting the healthcare needs of the U.S. military and veterans through its extensive federal contract portfolio with the DLA and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 3/10/23 |